VTL Vital Therapies Inc.

0.22
0  -2%
Previous Close 0.22
Open 0.24
Price To Book 0.64
Market Cap 9295911
Shares 42,369,694
Volume 382,979
Short Ratio
Av. Daily Volume 1,145,927

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released September 11, 2018 - endpoints not met.
VTI-308
Alcohol-induced liver decompensation, or AILD
Terminated September 2015 in order to reduce costs
ELAD (VTI-210)
Severe acute alcoholic hepatitis
Terminated September 2015 in order to reduce costs
ELAD (VTI-212)
Fulminant hepatic failure, or FHF, or surgery-induced acute liver failure, or SILF